0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Human Microbiome Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-16L15854
Home | Market Reports | Science| Biological Sciences
Global and India Human Microbiome Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Human Microbiome Market Report & Forecast 2023-2029

Code: QYRE-Auto-16L15854
Report
November 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Microbiome Market Size

The global Human Microbiome revenue was US$ 384.9 million in 2022 and is forecast to a readjusted size of US$ 1544.9 million by 2029 with a CAGR of 21.7% during the review period (2023-2029).

and India Human Microbiome Market

Human Microbiome Market Trends

The human microbiome market is expanding as research institutions and healthcare providers increasingly explore microbiome-based treatments for gut, skin, and immune-related conditions. Growing understanding of microbial diversity and its impact on overall health is encouraging investment in diagnostic tools, supplements, and therapeutic formulations. Rising consumer interest in digestive wellness and immune support further propels demand for microbiome-oriented products.

India is becoming a significant contributor as local research programs and biotech firms intensify efforts to study indigenous microbiome patterns. Increased funding for microbiology research and rising acceptance of probiotic supplements support market expansion. Healthcare providers in the region are integrating microbiome insights into preventive care, nutrition planning, and chronic disease management, strengthening overall awareness.

Clinical studies focusing on personalized nutrition, metabolic disorders, and skin health are accelerating global interest in microbiome analysis. Companies are engaging in partnerships to develop standardized testing methods, improve sampling accuracy, and create targeted wellness products. The rise of home-based gut testing kits and microbiome-driven dietary plans reflects a shift toward personalized health solutions that depend on microbial data.

Human Microbiome Market Share 

North America dominates due to advanced research infrastructure and widespread adoption of microbiome-based wellness products, while Europe maintains strong activity through extensive clinical studies; India and broader Asia-Pacific regions are rapidly increasing their shares driven by expanding biotech capabilities, with Latin America and the Middle East showing steady growth as awareness and diagnostic accessibility improve.

Scope of and India Human Microbiome Market Report

Report Metric Details
Report Name and India Human Microbiome Market
Forecasted market size in 2029 US$ 1544.9 million
CAGR 21.7%
Forecasted years 2023 - 2029
Segment by Type
  • Gastrointestinal Tract Human Micobiome
  • Urogenital Tract Human Micobiome
  • Others
Segment by Application
  • Treatment
  • Diagnosis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Human Microbiome Market size in 2029?

Ans: The and India Human Microbiome Market size in 2029 will be US$ 1544.9 million.

What is the and India Human Microbiome Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Human Microbiome Market report?

Ans: The main players in the and India Human Microbiome Market are Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC

What are the Application segmentation covered in the and India Human Microbiome Market report?

Ans: The Applications covered in the and India Human Microbiome Market report are Treatment, Diagnosis

What are the Type segmentation covered in the and India Human Microbiome Market report?

Ans: The Types covered in the and India Human Microbiome Market report are Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Others

1 Study Coverage
1.1 Human Microbiome Product Introduction
1.2 Global Human Microbiome Outlook 2018 VS 2022 VS 2029
1.2.1 Global Human Microbiome Market Size for the Year 2018-2029
1.2.2 India Human Microbiome Market Size for the Year 2018-2029
1.3 Human Microbiome Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Human Microbiome in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Human Microbiome Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Human Microbiome Market Dynamics
1.4.1 Human Microbiome Industry Trends
1.4.2 Human Microbiome Market Drivers
1.4.3 Human Microbiome Market Challenges
1.4.4 Human Microbiome Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Human Microbiome by Type
2.1 Human Microbiome Market Segment by Type
2.1.1 Gastrointestinal Tract Human Micobiome
2.1.2 Urogenital Tract Human Micobiome
2.1.3 Others
2.2 Global Human Microbiome Market Size by Type (2018, 2022 & 2029)
2.3 Global Human Microbiome Market Size by Type (2018-2029)
2.4 India Human Microbiome Market Size by Type (2018, 2022 & 2029)
2.5 India Human Microbiome Market Size by Type (2018-2029)
3 Human Microbiome by Application
3.1 Human Microbiome Market Segment by Application
3.1.1 Treatment
3.1.2 Diagnosis
3.2 Global Human Microbiome Market Size by Application (2018, 2022 & 2029)
3.3 Global Human Microbiome Market Size by Application (2018-2029)
3.4 India Human Microbiome Market Size by Application (2018, 2022 & 2029)
3.5 India Human Microbiome Market Size by Application (2018-2029)
4 Global Human Microbiome Competitor Landscape by Company
4.1 Global Human Microbiome Market Size by Company
4.1.1 Global Key Companies of Human Microbiome, Ranked by Revenue (2022)
4.1.2 Global Human Microbiome Revenue by Player (2018-2023)
4.2 Global Human Microbiome Concentration Ratio (CR)
4.2.1 Human Microbiome Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Human Microbiome in 2022
4.2.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Human Microbiome Head office and Area Served
4.4 Global Key Players of Human Microbiome, Product and Application
4.5 Global Key Players of Human Microbiome, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Human Microbiome Market Size by Company
4.7.1 Key Players of Human Microbiome in India, Ranked by Revenue (2022)
4.7.2 India Human Microbiome Revenue by Players (2021, 2022 & 2023)
5 Global Human Microbiome Market Size by Region
5.1 Global Human Microbiome Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Human Microbiome Market Size by Region (2018-2029)
5.2.1 Global Human Microbiome Market Size by Region: 2018-2023
5.2.2 Global Human Microbiome Market Size by Region (2024-2029)
6 Americas
6.1 Americas Human Microbiome Market Size YoY Growth 2018-2029
6.2 Americas Human Microbiome Market Size by Type
6.2.1 Americas Human Microbiome Market Size by Type (2018-2023)
6.2.2 Americas Human Microbiome Market Size by Type (2024-2029)
6.2.3 Americas Human Microbiome Market Share by Type (2018-2029)
6.3 Americas Human Microbiome Market Size by Application
6.3.1 Americas Human Microbiome Market Size by Application (2018-2023)
6.3.2 Americas Human Microbiome Market Size by Application (2024-2029)
6.3.3 Americas Human Microbiome Market Share by Application (2018-2029)
6.4 Americas Human Microbiome Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Human Microbiome Market Size YoY Growth 2018-2029
7.2 EMEA Human Microbiome Market Size by Type
7.2.1 EMEA Human Microbiome Market Size by Type (2018-2023)
7.2.2 EMEA Human Microbiome Market Size by Type (2024-2029)
7.2.3 EMEA Human Microbiome Market Share by Type (2018-2029)
7.3 EMEA Human Microbiome Market Size by Application
7.3.1 EMEA Human Microbiome Market Size by Application (2018-2023)
7.3.2 EMEA Human Microbiome Market Size by Application (2024-2029)
7.3.3 EMEA Human Microbiome Market Share by Application (2018-2029)
7.4 EMEA Human Microbiome Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Human Microbiome Market Size YoY Growth 2018-2029
8.2 China Human Microbiome Market Size by Type
8.2.1 China Human Microbiome Market Size by Type (2018-2023)
8.2.2 China Human Microbiome Market Size by Type (2024-2029)
8.2.3 China Human Microbiome Market Share by Type (2018-2029)
8.3 China Human Microbiome Market Size by Application
8.3.1 China Human Microbiome Market Size by Application (2018-2023)
8.3.2 China Human Microbiome Market Size by Application (2024-2029)
8.3.3 China Human Microbiome Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Human Microbiome Market Size YoY Growth 2018-2029
9.2 APAC Human Microbiome Market Size by Type
9.2.1 APAC Human Microbiome Market Size by Type (2018-2023)
9.2.2 APAC Human Microbiome Market Size by Type (2024-2029)
9.2.3 APAC Human Microbiome Market Share by Type (2018-2029)
9.3 APAC Human Microbiome Market Size by Application
9.3.1 APAC Human Microbiome Market Size by Application (2018-2023)
9.3.2 APAC Human Microbiome Market Size by Application (2024-2029)
9.3.3 APAC Human Microbiome Market Share by Application (2018-2029)
9.4 APAC Human Microbiome Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Vedanta
10.1.1 Vedanta Company Details
10.1.2 Vedanta Business Overview
10.1.3 Vedanta Human Microbiome Introduction
10.1.4 Vedanta Revenue in Human Microbiome Business (2018-2023)
10.1.5 Vedanta Recent Development
10.2 Seres Therapeutics
10.2.1 Seres Therapeutics Company Details
10.2.2 Seres Therapeutics Business Overview
10.2.3 Seres Therapeutics Human Microbiome Introduction
10.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2018-2023)
10.2.5 Seres Therapeutics Recent Development
10.3 Second Genome
10.3.1 Second Genome Company Details
10.3.2 Second Genome Business Overview
10.3.3 Second Genome Human Microbiome Introduction
10.3.4 Second Genome Revenue in Human Microbiome Business (2018-2023)
10.3.5 Second Genome Recent Development
10.4 Rebiotix
10.4.1 Rebiotix Company Details
10.4.2 Rebiotix Business Overview
10.4.3 Rebiotix Human Microbiome Introduction
10.4.4 Rebiotix Revenue in Human Microbiome Business (2018-2023)
10.4.5 Rebiotix Recent Development
10.5 ActoGeniX
10.5.1 ActoGeniX Company Details
10.5.2 ActoGeniX Business Overview
10.5.3 ActoGeniX Human Microbiome Introduction
10.5.4 ActoGeniX Revenue in Human Microbiome Business (2018-2023)
10.5.5 ActoGeniX Recent Development
10.6 Enterome BioScience
10.6.1 Enterome BioScience Company Details
10.6.2 Enterome BioScience Business Overview
10.6.3 Enterome BioScience Human Microbiome Introduction
10.6.4 Enterome BioScience Revenue in Human Microbiome Business (2018-2023)
10.6.5 Enterome BioScience Recent Development
10.7 AvidBiotics
10.7.1 AvidBiotics Company Details
10.7.2 AvidBiotics Business Overview
10.7.3 AvidBiotics Human Microbiome Introduction
10.7.4 AvidBiotics Revenue in Human Microbiome Business (2018-2023)
10.7.5 AvidBiotics Recent Development
10.8 4D Pharma Research Ltd
10.8.1 4D Pharma Research Ltd Company Details
10.8.2 4D Pharma Research Ltd Business Overview
10.8.3 4D Pharma Research Ltd Human Microbiome Introduction
10.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2018-2023)
10.8.5 4D Pharma Research Ltd Recent Development
10.9 Enterologics
10.9.1 Enterologics Company Details
10.9.2 Enterologics Business Overview
10.9.3 Enterologics Human Microbiome Introduction
10.9.4 Enterologics Revenue in Human Microbiome Business (2018-2023)
10.9.5 Enterologics Recent Development
10.10 Metabogen
10.10.1 Metabogen Company Details
10.10.2 Metabogen Business Overview
10.10.3 Metabogen Human Microbiome Introduction
10.10.4 Metabogen Revenue in Human Microbiome Business (2018-2023)
10.10.5 Metabogen Recent Development
10.11 Metabiomics
10.11.1 Metabiomics Company Details
10.11.2 Metabiomics Business Overview
10.11.3 Metabiomics Human Microbiome Introduction
10.11.4 Metabiomics Revenue in Human Microbiome Business (2018-2023)
10.11.5 Metabiomics Recent Development
10.12 Ritter Pharmaceuticals
10.12.1 Ritter Pharmaceuticals Company Details
10.12.2 Ritter Pharmaceuticals Business Overview
10.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
10.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2018-2023)
10.12.5 Ritter Pharmaceuticals Recent Development
10.13 Osel
10.13.1 Osel Company Details
10.13.2 Osel Business Overview
10.13.3 Osel Human Microbiome Introduction
10.13.4 Osel Revenue in Human Microbiome Business (2018-2023)
10.13.5 Osel Recent Development
10.14 Symberix
10.14.1 Symberix Company Details
10.14.2 Symberix Business Overview
10.14.3 Symberix Human Microbiome Introduction
10.14.4 Symberix Revenue in Human Microbiome Business (2018-2023)
10.14.5 Symberix Recent Development
10.15 Miomics
10.15.1 Miomics Company Details
10.15.2 Miomics Business Overview
10.15.3 Miomics Human Microbiome Introduction
10.15.4 Miomics Revenue in Human Microbiome Business (2018-2023)
10.15.5 Miomics Recent Development
10.16 Symbiotix Biotherapies
10.16.1 Symbiotix Biotherapies Company Details
10.16.2 Symbiotix Biotherapies Business Overview
10.16.3 Symbiotix Biotherapies Human Microbiome Introduction
10.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2018-2023)
10.16.5 Symbiotix Biotherapies Recent Development
10.17 MicroBiome Therapeutics LLC
10.17.1 MicroBiome Therapeutics LLC Company Details
10.17.2 MicroBiome Therapeutics LLC Business Overview
10.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
10.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2018-2023)
10.17.5 MicroBiome Therapeutics LLC Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Tables
    Table 1. Human Microbiome Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Human Microbiome Market Trends
    Table 3. Human Microbiome Market Drivers
    Table 4. Human Microbiome Market Challenges
    Table 5. Human Microbiome Market Restraints
    Table 6. Global Human Microbiome Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Human Microbiome Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Human Microbiome Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Human Microbiome Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Human Microbiome, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Human Microbiome Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Human Microbiome Revenue Share by Player, 2018-2023
    Table 13. Global Human Microbiome Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2022)
    Table 15. Global Key Players of Human Microbiome, Headquarters and Area Served
    Table 16. Global Key Players of Human Microbiome, Product and Application
    Table 17. Global Key Players of Human Microbiome, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Human Microbiome in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Human Microbiome Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Human Microbiome Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Human Microbiome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Human Microbiome Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Human Microbiome Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Human Microbiome Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Human Microbiome Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Human Microbiome Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Human Microbiome Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Human Microbiome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Human Microbiome Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Human Microbiome Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Human Microbiome Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Human Microbiome Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Human Microbiome Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Human Microbiome Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Human Microbiome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Human Microbiome Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Human Microbiome Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Human Microbiome Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Human Microbiome Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Human Microbiome Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Human Microbiome Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Human Microbiome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Human Microbiome Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Human Microbiome Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Human Microbiome Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Human Microbiome Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Human Microbiome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Human Microbiome Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Human Microbiome Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Vedanta Company Details
    Table 52. Vedanta Business Overview
    Table 53. Vedanta Human Microbiome Product
    Table 54. Vedanta Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 55. Vedanta Recent Development
    Table 56. Seres Therapeutics Company Details
    Table 57. Seres Therapeutics Business Overview
    Table 58. Seres Therapeutics Human Microbiome Product
    Table 59. Seres Therapeutics Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 60. Seres Therapeutics Recent Development
    Table 61. Second Genome Company Details
    Table 62. Second Genome Business Overview
    Table 63. Second Genome Human Microbiome Product
    Table 64. Second Genome Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 65. Second Genome Recent Development
    Table 66. Rebiotix Company Details
    Table 67. Rebiotix Business Overview
    Table 68. Rebiotix Human Microbiome Product
    Table 69. Rebiotix Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 70. Rebiotix Recent Development
    Table 71. ActoGeniX Company Details
    Table 72. ActoGeniX Business Overview
    Table 73. ActoGeniX Human Microbiome Product
    Table 74. ActoGeniX Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 75. ActoGeniX Recent Development
    Table 76. Enterome BioScience Company Details
    Table 77. Enterome BioScience Business Overview
    Table 78. Enterome BioScience Human Microbiome Product
    Table 79. Enterome BioScience Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 80. Enterome BioScience Recent Development
    Table 81. AvidBiotics Company Details
    Table 82. AvidBiotics Business Overview
    Table 83. AvidBiotics Human Microbiome Product
    Table 84. AvidBiotics Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 85. AvidBiotics Recent Development
    Table 86. 4D Pharma Research Ltd Company Details
    Table 87. 4D Pharma Research Ltd Business Overview
    Table 88. 4D Pharma Research Ltd Human Microbiome Product
    Table 89. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 90. 4D Pharma Research Ltd Recent Development
    Table 91. Enterologics Company Details
    Table 92. Enterologics Business Overview
    Table 93. Enterologics Human Microbiome Product
    Table 94. Enterologics Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 95. Enterologics Recent Development
    Table 96. Metabogen Company Details
    Table 97. Metabogen Business Overview
    Table 98. Metabogen Human Microbiome Product
    Table 99. Metabogen Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 100. Metabogen Recent Development
    Table 101. Metabiomics Company Details
    Table 102. Metabiomics Business Overview
    Table 103. Metabiomics Human Microbiome Product
    Table 104. Metabiomics Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 105. Metabiomics Recent Development
    Table 106. Ritter Pharmaceuticals Company Details
    Table 107. Ritter Pharmaceuticals Business Overview
    Table 108. Ritter Pharmaceuticals Human Microbiome Product
    Table 109. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 110. Ritter Pharmaceuticals Recent Development
    Table 111. Osel Company Details
    Table 112. Osel Business Overview
    Table 113. Osel Human Microbiome Product
    Table 114. Osel Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 115. Osel Recent Development
    Table 116. Symberix Company Details
    Table 117. Symberix Business Overview
    Table 118. Symberix Human Microbiome Product
    Table 119. Symberix Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 120. Symberix Recent Development
    Table 121. Miomics Company Details
    Table 122. Miomics Business Overview
    Table 123. Miomics Human Microbiome Product
    Table 124. Miomics Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 125. Miomics Recent Development
    Table 126. Symbiotix Biotherapies Company Details
    Table 127. Symbiotix Biotherapies Business Overview
    Table 128. Symbiotix Biotherapies Human Microbiome Product
    Table 129. Symbiotix Biotherapies Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 130. Symbiotix Biotherapies Recent Development
    Table 131. MicroBiome Therapeutics LLC Company Details
    Table 132. MicroBiome Therapeutics LLC Business Overview
    Table 133. MicroBiome Therapeutics LLC Human Microbiome Product
    Table 134. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2018-2023) & (US$ Million)
    Table 135. MicroBiome Therapeutics LLC Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Microbiome Product Picture
    Figure 2. Global Human Microbiome Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Human Microbiome Market Size 2018-2029 (US$ Million)
    Figure 4. India Human Microbiome Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Human Microbiome Market Size 2018-2029 (US$ Million)
    Figure 6. India Human Microbiome Market Share in Global 2018-2029
    Figure 7. Human Microbiome Report Years Considered
    Figure 8. Product Picture of Gastrointestinal Tract Human Micobiome
    Figure 9. Product Picture of Urogenital Tract Human Micobiome
    Figure 10. Product Picture of Others
    Figure 11. Global Human Microbiome Market Share by Type in 2022 & 2029
    Figure 12. Global Human Microbiome Market Size by Type (2018-2029) & (US$ Million)
    Figure 13. Global Human Microbiome Market Share by Type (2018-2029)
    Figure 14. India Human Microbiome Market Share by Type in 2022 & 2029
    Figure 15. India Human Microbiome Market Size by Type (2018-2029) & (US$ Million)
    Figure 16. India Human Microbiome Market Share by Type (2018-2029)
    Figure 17. Product Picture of Treatment
    Figure 18. Product Picture of Diagnosis
    Figure 19. Global Human Microbiome Market Share by Application in 2022 & 2029
    Figure 20. Global Human Microbiome Market Size by Application (2018-2029) & (US$ Million)
    Figure 21. Global Human Microbiome Market Share by Application (2018-2029)
    Figure 22. India Human Microbiome Market Share by Application in 2022 & 2029
    Figure 23. India Human Microbiome Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. India Human Microbiome Market Share by Application (2018-2029)
    Figure 25. The Top 5 and 10 Largest Companies of Human Microbiome in the World: Market Share by Human Microbiome Revenue in 2022
    Figure 26. Global Human Microbiome Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 27. Global Human Microbiome Market Share by Region (2018-2029)
    Figure 28. Americas Human Microbiome Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 29. Americas Human Microbiome Market Share by Type (2018-2029)
    Figure 30. Americas Human Microbiome Market Share by Application (2018-2029)
    Figure 31. United States Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Canada Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Mexico Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Brazil Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. EMEA Human Microbiome Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 36. EMEA Human Microbiome Market Share by Type (2018-2029)
    Figure 37. EMEA Human Microbiome Market Share by Application (2018-2029)
    Figure 38. Europe Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Middle East Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Africa Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. China Human Microbiome Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 42. China Human Microbiome Market Share by Type (2018-2029)
    Figure 43. China Human Microbiome Market Share by Application (2018-2029)
    Figure 44. APAC Human Microbiome Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. APAC Human Microbiome Market Share by Type (2018-2029)
    Figure 46. APAC Human Microbiome Market Share by Application (2018-2029)
    Figure 47. Japan Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 48. South Korea Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. China Taiwan Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. India Human Microbiome Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Vedanta Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 53. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 54. Second Genome Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 55. Rebiotix Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 56. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 57. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 58. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 59. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 60. Enterologics Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 61. Metabogen Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 62. Metabiomics Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 63. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 64. Osel Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 65. Symberix Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 66. Miomics Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 67. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 68. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2018-2023)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart